Viewing Study NCT05555303


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2025-12-25 @ 5:17 PM
Study NCT ID: NCT05555303
Status: RECRUITING
Last Update Posted: 2023-03-29
First Post: 2022-09-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Preventing Acquired Resistance: Strengthen TB Treatment by Adding Amikacin in the First Treatment Week of Multidrug-resistant Tuberculosis
Sponsor: Rwanda Biomedical Centre
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module